Platelets: Guardians of tumor vasculature

Cancer Research

Volumn 69, Issue 14, 2009, Pages 5623-5626

  Ho Tin Noé, Benoit ^a,b,c   Goerge, Tobias ^a,b,d   Wagner, Denisa D ^a,b  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE; SEROTONIN; SPHINGOSINE 1 PHOSPHATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANGIOGENESIS; CARCINOGENESIS; CELL INTERACTION; CYTOKINE RELEASE; HOMEOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; TUMOR BLEEDING; TUMOR VASCULARIZATION;

ANIMALS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET ACTIVATION;

EID: 67650999097     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1370     Document Type: Review

References (31)

1. Trousseau A. Phlegmatia alba dolens, vol. 3. Paris: JB Baillere et Fils; 1865. p. 654-712.
2. Amin C, Mackman N, Key NS. Microparticles and cancer. Pathophysiol Haemost Thromb 2008;36:177-83.
3. Dvorak HF, Nagy JA, Berse B, et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci 1992;667:101-11.
4. Nash GF, Turner LF, Scully MF, Kakkar AK. Platelets and cancer. Lancet Oncol 2002;3:425-30.
5. Pinedo HM, Verheul HM, D'Amato RJ, Folkman J. Involvement of platelets in tumour angiogenesis? Lancet 1998;352:1775-7.
6. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 1968;61:46-52.
7. Karpatkin S, Pearlstein E, Salk PL, Yogeeswaran G. Role of platelets in tumor cell metastases. Ann N Y Acad Sci 1981;370:101-18.
8. Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999;59:1295-300.
9. Italiano JE, Jr., Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet α granules and differentially released. Blood 2008;111:1227-33.
10. Kisucka J, Butterfield CE, Duda DG, et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A 2006;103:855-60.
11. Goerge T, Ho-Tin-Noe B, Carbo C, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood 2008;111:4958-64.
12. Ho-Tin-Noe B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008;68:6851-8.
13. Manegold PC, Hutter J, Pahernik SA, Messmer K, Dellian M. Platelet-endothelial interaction in tumor angiogenesis and microcirculation. Blood 2003;101:1970-6.
14. Boneu B, Bugat R, Boneu A, Eche N, Sie P, Combes PF. Exhausted platelets in patients with malignant solid tumors without evidence of active consumption coagulopathy. Eur J Cancer Clin Oncol 1984;20:899-903.
15. Danielli JF. Capillary permeability and oedema in the perfused frog. J Physiol 1940;98:109-29.
16. Gimbrone MA, Jr., Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 1969;222:33-6.
17. D'Amore P. First annual Lamport award manuscript. Platelet-endothelial interaction and the maintenance of the microvasculature. Microvasc Res 1978;15:137-45.
18. Kitchens CS, Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia. Blood 1975;46:567-78.
19. Li JJ, Huang YQ, Basch R, Karpatkin S. Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost 2001;85:204-6.
20. Shepro D, Welles SL, Hechtman HB. Vasoactive agonists prevent erythrocyte extravasation in thrombocytopenic hamsters. Thromb Res 1984;35:421-30.
21. Schaphorst KL, Chiang E, Jacobs KN, et al. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol 2003;285:L258-67.
22. Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 2008;359:1261-70.
23. Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003;163:1801-15.
24. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006;1:119-50.
25. Mansilla S, Boulaftali Y, Venisse L, et al. Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2008;28:1844-50.
26. Radomski A, Jurasz P, Sanders EJ, et al. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br J Pharmacol 2002;137:1330-8.
27. McGarrity ST, Stephenson AH, Hyers TM, Webster RO. Inhibition of neutrophil superoxide anion generation by platelet products: role of adenine nucleotides. J Leukoc Biol 1988;44:411-21.
28. Cognasse F, Hamzeh-Cognasse H, Lafarge S, et al. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 2008;141:84-91.
29. Cleator JH, Zhu WQ, Vaughan DE, Hamm HE. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP. Blood 2006;107:2736-44.
30. Caine GJ, Lip GY, Blann AD. Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis. Ann Med 2004;36:273-7.
31. Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res 2007;74:72-84.